Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005095294 | SCV005753631 | pathogenic | not provided | 2024-05-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg206Alafs*18) in the PBX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PBX1 are known to be pathogenic (PMID: 28566479, 29036646, 29226118). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PBX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1339930). For these reasons, this variant has been classified as Pathogenic. |
Genome |
RCV001825313 | SCV002075183 | not provided | Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay | no assertion provided | phenotyping only | Variant interpreted as Pathogenic and reported on 05-28-2021 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |